/ Estimated Power Approach / FDA Draft Guidance / gene therapy evaluation / Group Sequential Design / interim analysis / Master Protocols / MATHEMATICS / General / MATHEMATICS / Probability & Statistics / General / MATHEMATICS / Study & Teaching / n-of-1 methodology / Non-inferiority Margin / orphan drug approval / Pharmaceutical chemistry and technology / Pharmaceutical technology / Platform Trial / Probability & statistics / Probability and statistics / rare disease / real-world evidence analysis / Reference Product / Regulatory Science / Reproducibility Probability / Smaller Patient Population / Study Endpoints / Surrogate endpoint / Test Treatment / trial design